WWC proteins mediate LATS1/2 activation by Hippo kinases and imply a tumor suppression strategy
Sixian Qi,Yuwen Zhu,Xincheng Liu,Pengyue Li,Yebin Wang,Yan Zeng,Aijuan Yu,Yu Wang,Zhao Sha,Zhenxing Zhong,Rui Zhu,Haixin Yuan,Dan Ye,Shenglin Huang,Chen Ling,Yanhui Xu,Dawang Zhou,Lei Zhang,Fa-Xing Yu
DOI: https://doi.org/10.1016/j.molcel.2022.03.027
IF: 16
2022-04-01
Molecular Cell
Abstract:SummaryYAP and TAZ (YAP/TAZ), two major effectors of the Hippo signaling pathway, are frequently activated in human cancers. The activity of YAP/TAZ is strictly repressed upon phosphorylation by LATS1/2 tumor suppressors. However, it is unclear how LATS1/2 are precisely regulated by upstream factors such as Hippo kinases MST1/2. Here, we show that WWC proteins (WWC1/2/3) directly interact with LATS1/2 and SAV1, and SAV1, in turn, brings in MST1/2 to phosphorylate and activate LATS1/2. Hence, WWC1/2/3 play an organizer role in a signaling module that mediates LATS1/2 activation by MST1/2. Moreover, we have defined a minimum protein interaction interface on WWC1/2/3 that is sufficient to activate LATS1/2 in a robust and specific manner. The corresponding minigene, dubbed as SuperHippo, can effectively suppress tumorigenesis in multiple tumor models. Our study has uncovered a molecular mechanism underlying LATS1/2 regulation and provides a strategy for treating diverse malignancies related to Hippo pathway dysregulation.
cell biology,biochemistry & molecular biology